AGN

» Auto updated continuously

Display limited to 'AGN' in document titles and meta descriptions. Display In Whole Documents or use the calendar above to adjust the date setting.

 2018-09-17 18:00 

Markets Insider

In a bid to appeal to millennials, Botox-maker Allergan is asking them if they're 'bo-curious' (AGN)...
 2018-09-17 17:53 

Business Insider

In a bid to appeal to millennials, Botox-maker Allergan is asking them if they're 'bo-curious' (AGN)...

Allergan's plan to grow its Botox and fillers businesses relies in large part on getting millennials to use its products. The drug company is launching a handful of millennial-focused campaigns including one that poses the question: "Are you bo-cu...

 2018-09-14 20:15 

Markets Insider

Allergan Announces Results of Higher Dose BOTOX Cosmetic (onabotulinumtoxinA) for the Treatment of Moderate to Severe Glabellar Lines...

DUBLIN, Sept. 14, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced clinical study results of higher doses of BOTOX Cosmetic compared to BOTOX Cosmetic 20 unit dose at week 24 in patients with moderate to severe glabellar......

 2018-09-14 19:00 

Markets Insider

Allergan Highlights Key Growth Drivers for Medical Aesthetics...

DUBLIN, Sept. 14, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN) today hosted its first ever Medical Aesthetics Analyst Day where the Company outlined its industry-leading portfolio and pipeline and key initiatives to drive future growth, as well as......

 2018-09-14 13:39 

Markets Insider

Allergan To Buy Bonti For Upfront Payment Of $195 Mln & Addl Milestone Payments...

(RTTNews) - Allergan plc (AGN) said that it has agreed to acquire Bonti Inc. for an upfront payment of $195 million and additional potential commercial milestone payments, subject to certain adjustments and other customary closing conditions.Bonti is a pr...

 2018-09-14 13:15 

Markets Insider

Allergan to Acquire Bonti Adding New Neurotoxin Programs to Medical Aesthetics Pipeline...

DUBLIN and NEWPORT BEACH, Calif., Sept. 14, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced it has agreed to acquire Bonti, Inc., a privately held clinical-stage biotechnology......

 2018-09-12 11:30 

Business Insider

The maker of Botox is going after millennials who are thinking about wrinkle-smoothing treatments and has hired a fashion and beauty executive to lead its effort (AGN)...

Drugmaker Allergan has a plan to grow the medical aesthetics market and confront competition to its blockbuster Botox drug. It's launching a website called Spotlyte with the help of Gilt Groupe co-founder Alexandra Wilkis Wilson, who joined the drug c...

 2018-09-05 16:07 

The Street

Allergan CEO: Botox Is in a Very Strong Position...

The entrance of more competition for Botox Cosmetic could expand the market, the drugmaker's top executive says at the Wells Fargo Healthcare Conference in Boston....

 2018-08-29 21:00 

Markets Insider

Allergan Continues Board Refreshment Process...

DUBLIN, Aug. 29, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that Paul Bisaro will be retiring from its Board of Directors, as part of the company's ongoing board refreshment process. Mr. Bisaro has served on the......

 2018-08-29 14:54 

WorldNetDaily

Bedtime ritual...

Editor's note: Do you need something to smile about? Every day, WND selects the best joke offered up by readers and contributors to its Laughlines forum and brings it to you as the WND Joke of the Day. Here is today's offering: Q: What does an agn...

 2018-08-27 07:00 

The Guardian

Agns Varda, the queen of the meme...

As her documentaries get a fresh run in the UK, it's clear that the 90-year-old director of Faces Places and The Gleaners and I was always ahead of her time...

 2018-08-22 13:21 

Markets Insider

The FDA just rejected Allergan's women's health drug (AGN)...

Markets Insider...

 2018-08-22 00:56 

Markets Insider

Allergan Gets CRL From FDA For Ulipristal Acetate NDA...

(RTTNews) - Allergan plc (AGN) said it received a Complete Response Letter or CRL from the U.S. Food and Drug Administration in response to the New Drug Application or NDA for ulipristal acetate or UPA for the treatment of abnormal uterine bleeding in wom...

Page 1 of 1

  • Need an account?  
    or